APO Research
Talk to an analyst

APO RESEARCH · REPORT

Eszopiclone Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Eszopiclone Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchEszopiclone Drug Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Eszopiclone Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Eszopiclone Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Eszopiclone Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Eszopiclone Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Eszopiclone Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Eszopiclone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Eszopiclone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Eszopiclone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Eszopiclone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Eszopiclone Drug include Teva, Sun Pharmaceutical, Mylan, West Ward Pharmaceuticals, Sunovion, McKesson Medical-Surgical, Lupin Pharmaceuticals, Glenmark Pharmaceuticals and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Eszopiclone Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Eszopiclone Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Eszopiclone Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Eszopiclone Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Eszopiclone Drug Segment by Company

Teva

Sun Pharmaceutical

Mylan

West Ward Pharmaceuticals

Sunovion

McKesson Medical-Surgical

Lupin Pharmaceuticals

Glenmark Pharmaceuticals

Dr. Reddy's Laboratories

Aurobindo Pharma

Eszopiclone Drug Segment by Type

1 mg Tablets

2 mg Tablets

3 mg Tablets

Eszopiclone Drug Segment by Application

Hospital

Drug store

Eszopiclone Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eszopiclone Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Eszopiclone Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eszopiclone Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Eszopiclone Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Eszopiclone Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Eszopiclone Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Eszopiclone Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Eszopiclone Drug Industry Trends Table 2. Eszopiclone Drug Industry Drivers Table 3. Eszopiclone Drug Industry Opportunities and Challenges Table 4. Eszopiclone Drug Industry Restraints Table 5. Global Eszopiclone Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Eszopiclone Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Eszopiclone Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Eszopiclone Drug Sales Market Share by Manufacturers Table 9. Global Eszopiclone Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Eszopiclone Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Eszopiclone Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Eszopiclone Drug Manufacturers, Product Type & Application Table 13. Global Eszopiclone Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Eszopiclone Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1 mg Tablets Table 17. Major Manufacturers of 2 mg Tablets Table 18. Major Manufacturers of 3 mg Tablets Table 19. Global Eszopiclone Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Eszopiclone Drug Sales by Type (2021-2026) & (k units) Table 21. Global Eszopiclone Drug Sales by Type (2027-2032) & (k units) Table 22. Global Eszopiclone Drug Sales Market Share by Type (2021-2026) Table 23. Global Eszopiclone Drug Sales Market Share by Type (2027-2032) Table 24. Global Eszopiclone Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Eszopiclone Drug Revenue by Type (2021-2026) & (k units) Table 26. Global Eszopiclone Drug Revenue by Type (2027-2032) & (k units) Table 27. Global Eszopiclone Drug Revenue Market Share by Type (2021-2026) Table 28. Global Eszopiclone Drug Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Drug store Table 31. Global Eszopiclone Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Eszopiclone Drug Sales by Application (2021-2026) & (k units) Table 33. Global Eszopiclone Drug Sales by Application (2027-2032) & (k units) Table 34. Global Eszopiclone Drug Sales Market Share by Application (2021-2026) Table 35. Global Eszopiclone Drug Sales Market Share by Application (2027-2032) Table 36. Global Eszopiclone Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Eszopiclone Drug Revenue by Application (2021-2026) & (k units) Table 38. Global Eszopiclone Drug Revenue by Application (2027-2032) & (k units) Table 39. Global Eszopiclone Drug Revenue Market Share by Application (2021-2026) Table 40. Global Eszopiclone Drug Revenue Market Share by Application (2027-2032) Table 41. Global Eszopiclone Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Eszopiclone Drug Sales by Region (2021-2026) & (k units) Table 43. Global Eszopiclone Drug Sales Market Share by Region (2021-2026) Table 44. Global Eszopiclone Drug Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Eszopiclone Drug Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Eszopiclone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Eszopiclone Drug Sales by Country (2021-2026) & (k units) Table 48. North America Eszopiclone Drug Sales by Country (2027-2032) & (k units) Table 49. Europe Eszopiclone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Eszopiclone Drug Sales by Country (2021-2026) & (k units) Table 51. Europe Eszopiclone Drug Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Eszopiclone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Eszopiclone Drug Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Eszopiclone Drug Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Eszopiclone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Eszopiclone Drug Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Eszopiclone Drug Sales by Country (2027-2032) & (k units) Table 58. Global Eszopiclone Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Eszopiclone Drug Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Eszopiclone Drug Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Eszopiclone Drug Revenue Market Share by Region (2021-2026) Table 62. Global Eszopiclone Drug Revenue Market Share by Region (2027-2032) Table 63. Teva Company Information Table 64. Teva Business Overview Table 65. Teva Eszopiclone Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Teva Eszopiclone Drug Product Portfolio Table 67. Teva Recent Development Table 68. Sun Pharmaceutical Company Information Table 69. Sun Pharmaceutical Business Overview Table 70. Sun Pharmaceutical Eszopiclone Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sun Pharmaceutical Eszopiclone Drug Product Portfolio Table 72. Sun Pharmaceutical Recent Development Table 73. Mylan Company Information Table 74. Mylan Business Overview Table 75. Mylan Eszopiclone Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Mylan Eszopiclone Drug Product Portfolio Table 77. Mylan Recent Development Table 78. West Ward Pharmaceuticals Company Information Table 79. West Ward Pharmaceuticals Business Overview Table 80. West Ward Pharmaceuticals Eszopiclone Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. West Ward Pharmaceuticals Eszopiclone Drug Product Portfolio Table 82. West Ward Pharmaceuticals Recent Development Table 83. Sunovion Company Information Table 84. Sunovion Business Overview Table 85. Sunovion Eszopiclone Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sunovion Eszopiclone Drug Product Portfolio Table 87. Sunovion Recent Development Table 88. McKesson Medical-Surgical Company Information Table 89. McKesson Medical-Surgical Business Overview Table 90. McKesson Medical-Surgical Eszopiclone Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. McKesson Medical-Surgical Eszopiclone Drug Product Portfolio Table 92. McKesson Medical-Surgical Recent Development Table 93. Lupin Pharmaceuticals Company Information Table 94. Lupin Pharmaceuticals Business Overview Table 95. Lupin Pharmaceuticals Eszopiclone Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Lupin Pharmaceuticals Eszopiclone Drug Product Portfolio Table 97. Lupin Pharmaceuticals Recent Development Table 98. Glenmark Pharmaceuticals Company Information Table 99. Glenmark Pharmaceuticals Business Overview Table 100. Glenmark Pharmaceuticals Eszopiclone Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Glenmark Pharmaceuticals Eszopiclone Drug Product Portfolio Table 102. Glenmark Pharmaceuticals Recent Development Table 103. Dr. Reddy's Laboratories Company Information Table 104. Dr. Reddy's Laboratories Business Overview Table 105. Dr. Reddy's Laboratories Eszopiclone Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Dr. Reddy's Laboratories Eszopiclone Drug Product Portfolio Table 107. Dr. Reddy's Laboratories Recent Development Table 108. Aurobindo Pharma Company Information Table 109. Aurobindo Pharma Business Overview Table 110. Aurobindo Pharma Eszopiclone Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Aurobindo Pharma Eszopiclone Drug Product Portfolio Table 112. Aurobindo Pharma Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Eszopiclone Drug Distributors List Table 116. Eszopiclone Drug Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Eszopiclone Drug Product Image Figure 2. Global Eszopiclone Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Eszopiclone Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Eszopiclone Drug Sales (2021-2032) & (k units) Figure 5. Global Eszopiclone Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Eszopiclone Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1 mg Tablets Image Figure 9. 2 mg Tablets Image Figure 10. 3 mg Tablets Image Figure 11. Global Eszopiclone Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Eszopiclone Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Eszopiclone Drug Sales Market Share by Type (2021-2032) Figure 14. Global Eszopiclone Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Eszopiclone Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Eszopiclone Drug Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Drug store Image Figure 19. Global Eszopiclone Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Eszopiclone Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Eszopiclone Drug Sales Market Share by Application (2021-2032) Figure 22. Global Eszopiclone Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Eszopiclone Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Eszopiclone Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Eszopiclone Drug Sales Market Share by Country (2021-2032) Figure 27. U.S. Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Eszopiclone Drug Sales Market Share by Country (2021-2032) Figure 32. Germany Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Eszopiclone Drug Sales Market Share by Country (2021-2032) Figure 39. China Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Eszopiclone Drug Sales Market Share by Country (2021-2032) Figure 47. Brazil Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Eszopiclone Drug Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Eszopiclone Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Eszopiclone Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Eszopiclone Drug Revenue (2021-2032) & (US$ Million) Figure 58. North America Eszopiclone Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Eszopiclone Drug Revenue (2021-2032) & (US$ Million) Figure 60. Europe Eszopiclone Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Eszopiclone Drug Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Eszopiclone Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Eszopiclone Drug Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Eszopiclone Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Eszopiclone Drug Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Eszopiclone Drug Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 1 mg Tablets
  • 2 mg Tablets
  • 3 mg Tablets
Applications
  • Hospital
  • Drug store
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Mylan
  • West Ward Pharmaceuticals
  • Sunovion
  • McKesson Medical-Surgical
  • Lupin Pharmaceuticals
  • Glenmark Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Eszopiclone Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Eszopiclone Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Eszopiclone Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Eszopiclone Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Eszopiclone Drug Market Dynamics
  1. 2.1 Eszopiclone Drug Industry Trends
  2. 2.2 Eszopiclone Drug Industry Drivers
  3. 2.3 Eszopiclone Drug Industry Opportunities and Challenges
  4. 2.4 Eszopiclone Drug Industry Restraints
3 Eszopiclone Drug Market by Manufacturers
  1. 3.1 Global Eszopiclone Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Eszopiclone Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Eszopiclone Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Eszopiclone Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Eszopiclone Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Eszopiclone Drug Manufacturers, Product Type & Application
  7. 3.7 Global Eszopiclone Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Eszopiclone Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Eszopiclone Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Eszopiclone Drug Tier 1, Tier 2, and Tier 3
4 Eszopiclone Drug Market by Type
  1. 4.1 Eszopiclone Drug Type Introduction
  2. 4.1.1 1 mg Tablets
  3. 4.1.2 2 mg Tablets
  4. 4.1.3 3 mg Tablets
  5. 4.2 Global Eszopiclone Drug Sales by Type
  6. 4.2.1 Global Eszopiclone Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Eszopiclone Drug Sales by Type (2021-2032)
  8. 4.2.3 Global Eszopiclone Drug Sales Market Share by Type (2021-2032)
  9. 4.3 Global Eszopiclone Drug Revenue by Type
  10. 4.3.1 Global Eszopiclone Drug Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Eszopiclone Drug Revenue by Type (2021-2032)
  12. 4.3.3 Global Eszopiclone Drug Revenue Market Share by Type (2021-2032)
5 Eszopiclone Drug Market by Application
  1. 5.1 Eszopiclone Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug store
  4. 5.2 Global Eszopiclone Drug Sales by Application
  5. 5.2.1 Global Eszopiclone Drug Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Eszopiclone Drug Sales by Application (2021-2032)
  7. 5.2.3 Global Eszopiclone Drug Sales Market Share by Application (2021-2032)
  8. 5.3 Global Eszopiclone Drug Revenue by Application
  9. 5.3.1 Global Eszopiclone Drug Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Eszopiclone Drug Revenue by Application (2021-2032)
  11. 5.3.3 Global Eszopiclone Drug Revenue Market Share by Application (2021-2032)
6 Global Eszopiclone Drug Sales by Region
  1. 6.1 Global Eszopiclone Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Eszopiclone Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Eszopiclone Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Eszopiclone Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Eszopiclone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Eszopiclone Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Eszopiclone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Eszopiclone Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Eszopiclone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Eszopiclone Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Eszopiclone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Eszopiclone Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Eszopiclone Drug Revenue by Region
  1. 7.1 Global Eszopiclone Drug Revenue by Region
  2. 7.1.1 Global Eszopiclone Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Eszopiclone Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Eszopiclone Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Eszopiclone Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Eszopiclone Drug Revenue (2021-2032)
  8. 7.2.2 North America Eszopiclone Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Eszopiclone Drug Revenue (2021-2032)
  11. 7.3.2 Europe Eszopiclone Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Eszopiclone Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Eszopiclone Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Eszopiclone Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Eszopiclone Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Eszopiclone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Eszopiclone Drug Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sun Pharmaceutical
  8. 8.2.1 Sun Pharmaceutical Company Information
  9. 8.2.2 Sun Pharmaceutical Business Overview
  10. 8.2.3 Sun Pharmaceutical Eszopiclone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Eszopiclone Drug Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Eszopiclone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Eszopiclone Drug Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 West Ward Pharmaceuticals
  20. 8.4.1 West Ward Pharmaceuticals Company Information
  21. 8.4.2 West Ward Pharmaceuticals Business Overview
  22. 8.4.3 West Ward Pharmaceuticals Eszopiclone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 West Ward Pharmaceuticals Eszopiclone Drug Product Portfolio
  24. 8.4.5 West Ward Pharmaceuticals Recent Developments
  25. 8.5 Sunovion
  26. 8.5.1 Sunovion Company Information
  27. 8.5.2 Sunovion Business Overview
  28. 8.5.3 Sunovion Eszopiclone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sunovion Eszopiclone Drug Product Portfolio
  30. 8.5.5 Sunovion Recent Developments
  31. 8.6 McKesson Medical-Surgical
  32. 8.6.1 McKesson Medical-Surgical Company Information
  33. 8.6.2 McKesson Medical-Surgical Business Overview
  34. 8.6.3 McKesson Medical-Surgical Eszopiclone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 McKesson Medical-Surgical Eszopiclone Drug Product Portfolio
  36. 8.6.5 McKesson Medical-Surgical Recent Developments
  37. 8.7 Lupin Pharmaceuticals
  38. 8.7.1 Lupin Pharmaceuticals Company Information
  39. 8.7.2 Lupin Pharmaceuticals Business Overview
  40. 8.7.3 Lupin Pharmaceuticals Eszopiclone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lupin Pharmaceuticals Eszopiclone Drug Product Portfolio
  42. 8.7.5 Lupin Pharmaceuticals Recent Developments
  43. 8.8 Glenmark Pharmaceuticals
  44. 8.8.1 Glenmark Pharmaceuticals Company Information
  45. 8.8.2 Glenmark Pharmaceuticals Business Overview
  46. 8.8.3 Glenmark Pharmaceuticals Eszopiclone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Glenmark Pharmaceuticals Eszopiclone Drug Product Portfolio
  48. 8.8.5 Glenmark Pharmaceuticals Recent Developments
  49. 8.9 Dr. Reddy's Laboratories
  50. 8.9.1 Dr. Reddy's Laboratories Company Information
  51. 8.9.2 Dr. Reddy's Laboratories Business Overview
  52. 8.9.3 Dr. Reddy's Laboratories Eszopiclone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dr. Reddy's Laboratories Eszopiclone Drug Product Portfolio
  54. 8.9.5 Dr. Reddy's Laboratories Recent Developments
  55. 8.10 Aurobindo Pharma
  56. 8.10.1 Aurobindo Pharma Company Information
  57. 8.10.2 Aurobindo Pharma Business Overview
  58. 8.10.3 Aurobindo Pharma Eszopiclone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Aurobindo Pharma Eszopiclone Drug Product Portfolio
  60. 8.10.5 Aurobindo Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Eszopiclone Drug Value Chain Analysis
  2. 9.1.1 Eszopiclone Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Eszopiclone Drug Production Mode & Process
  6. 9.2 Eszopiclone Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Eszopiclone Drug Distributors
  9. 9.2.3 Eszopiclone Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst